News Column

Natus Medical Updates on 2014 Annual and First Quarter Financial Guidance

January 24, 2014

Natus Medical Inc. announced its financial guidance for the first quarter and full year 2014. In a release on January 13 , the Company noted that for the full year 2014, the Company expects to report revenue of $345 million to $350 million and non-GAAP earnings per share of $1.12 to $1.16 . For the first quarter of 2014, the Company expects to report revenue of $82 million to $86 million and non-GAAP earnings per share of $0.21 to $0.24 , an increase of 33 percent to 53 percent over the first quarter of 2013 non-GAAP earnings per share of $0.15 . The Company expects to report revenue of approximately $90.0 to $90.5 million for the fourth quarter of 2013. The Company's guidance for the fourth quarter was $87 to $90 million . As previously announced, the Company will release its 2013 fourth quarter financial results before the market opens on Wednesday, January 29 . The Company's non-GAAP earnings per share guidance excludes charges for amortization expense associated with intangible assets from prior acquisitions, which the Company expects to be approximately $7.0 million and $1.7 million for the full year and first quarter 2014, respectively, and which the Company expects will reduce GAAP earnings per share by approximately $0.15 and $0.03 for the respective periods. The Company's non-GAAP guidance includes the impact of expensing employee equity compensation. All earnings per share amounts are on a diluted basis. Natus is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. ((Comments on this story may be sent to newsdesk@closeupmedia.com ))


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Professional Services Close - Up


Story Tools